NO178660C - Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser - Google Patents

Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser

Info

Publication number
NO178660C
NO178660C NO881407A NO881407A NO178660C NO 178660 C NO178660 C NO 178660C NO 881407 A NO881407 A NO 881407A NO 881407 A NO881407 A NO 881407A NO 178660 C NO178660 C NO 178660C
Authority
NO
Norway
Prior art keywords
6alkyl
aminocarbonyl
optionally substituted
piperazine
aryl
Prior art date
Application number
NO881407A
Other languages
English (en)
Norwegian (no)
Other versions
NO881407L (no
NO881407D0 (no
NO178660B (no
Inventor
Georges Henri Paul Van Daele
Freddy Francois Vlaeminck
Marc Gustaaf Celine Verdonck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO881407D0 publication Critical patent/NO881407D0/no
Publication of NO881407L publication Critical patent/NO881407L/no
Publication of NO178660B publication Critical patent/NO178660B/no
Publication of NO178660C publication Critical patent/NO178660C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
NO881407A 1987-04-01 1988-03-29 Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser NO178660C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3412987A 1987-04-01 1987-04-01

Publications (4)

Publication Number Publication Date
NO881407D0 NO881407D0 (no) 1988-03-29
NO881407L NO881407L (no) 1988-10-03
NO178660B NO178660B (no) 1996-01-29
NO178660C true NO178660C (no) 1996-05-08

Family

ID=21874492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881407A NO178660C (no) 1987-04-01 1988-03-29 Analogifremgangsmåte for fremstilling av N-aryl-piperazinalkanamidforbindelser

Country Status (21)

Country Link
EP (2) EP0727421B1 (de)
JP (1) JP2574377B2 (de)
KR (1) KR960016539B1 (de)
AT (2) ATE142627T1 (de)
AU (1) AU609790B2 (de)
CA (1) CA1315790C (de)
DE (2) DE3856501T2 (de)
DK (1) DK174878B1 (de)
ES (2) ES2091183T3 (de)
FI (1) FI97617C (de)
GR (1) GR3020983T3 (de)
HK (1) HK1006020A1 (de)
HU (2) HUT57740A (de)
IE (1) IE81057B1 (de)
IL (1) IL85919A (de)
NO (1) NO178660C (de)
NZ (1) NZ223847A (de)
PH (1) PH25507A (de)
PT (1) PT87118B (de)
RU (1) RU2014328C1 (de)
ZA (1) ZA882352B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840896A (en) * 1989-11-22 1998-11-24 Janssen Pharmaceutica, N.V. Method of preventing or limiting reperfusion damage
RU2093156C1 (ru) * 1989-11-22 1997-10-20 Жансен Фармасетика Н.В. L-(-)-2-(аминокарбонил)-n-(4-амино-2,6-дихлорфенил-4[5,5-бис(4-фторфенил)пентил]-1-пиперазинацетамид, его фармацевтически приемлемая кислотно-аддитивная соль или гидрат, способ его получения и средство для хранения сердца донора
JP2660086B2 (ja) * 1990-07-03 1997-10-08 明治製菓株式会社 脳及び心機能障害改善剤
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
ATE174913T1 (de) * 1992-07-31 1999-01-15 Bristol Myers Squibb Co Diphenyl oxazole-, thiazole- und imidazole- derivate als inhibitoren der wiederaufnahme des adenosins
EP0756593B1 (de) * 1994-04-20 2000-09-20 Lonza Ag Verfahren zur herstellung von 2-piperazincarbonsäurederivaten
CA2234342A1 (en) * 1997-04-10 1998-10-10 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
WO1998057643A1 (en) * 1997-06-16 1998-12-23 Janssen Pharmaceutica N.V. Use of draflazine-analogues for treating pain
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
WO2006074025A1 (en) 2004-12-30 2006-07-13 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN110511220B (zh) * 2018-05-22 2022-04-01 上海挚盟医药科技有限公司 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia

Also Published As

Publication number Publication date
EP0285219A2 (de) 1988-10-05
HU211129A9 (en) 1995-10-30
RU2014328C1 (ru) 1994-06-15
NO881407L (no) 1988-10-03
JPS63290869A (ja) 1988-11-28
FI97617C (fi) 1997-01-27
EP0285219A3 (de) 1991-07-03
KR880012566A (ko) 1988-11-28
FI881525A7 (fi) 1988-10-02
ES2167510T3 (es) 2002-05-16
DE3855520T2 (de) 1997-02-06
IE81057B1 (en) 1999-12-29
DK179788A (da) 1988-10-02
GR3020983T3 (en) 1996-12-31
ES2091183T3 (es) 1996-11-01
CA1315790C (en) 1993-04-06
IL85919A (en) 1992-12-01
PT87118A (pt) 1988-04-01
DK179788D0 (da) 1988-03-30
PT87118B (pt) 1992-07-31
ATE142627T1 (de) 1996-09-15
PH25507A (en) 1991-07-24
JP2574377B2 (ja) 1997-01-22
ZA882352B (en) 1989-12-27
AU1384788A (en) 1988-10-06
NO881407D0 (no) 1988-03-29
FI881525A0 (fi) 1988-03-31
IL85919A0 (en) 1988-09-30
EP0285219B1 (de) 1996-09-11
DE3855520D1 (de) 1996-10-17
EP0727421A1 (de) 1996-08-21
ATE207474T1 (de) 2001-11-15
DE3856501D1 (de) 2001-11-29
EP0727421B1 (de) 2001-10-24
NZ223847A (en) 1989-12-21
DK174878B1 (da) 2004-01-12
IE880989L (en) 1988-10-01
NO178660B (no) 1996-01-29
HK1006020A1 (en) 1999-02-05
AU609790B2 (en) 1991-05-09
DE3856501T2 (de) 2004-04-29
HUT57740A (en) 1991-12-30
FI97617B (fi) 1996-10-15
KR960016539B1 (ko) 1996-12-14

Similar Documents

Publication Publication Date Title
DE3176010D1 (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
HUT70426A (en) Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents
GR3004114T3 (de)
IL107961A0 (en) Phenoxy- and phenoxyalkyl-piperidines and pharmaceutical compositions containing them
ATE207474T1 (de) Schlafverbesserungsmittel
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
NO891176D0 (no) Fremstilling av antivirale tetrahydroimidazo(1,4)benzodiazepin-2-oner.
NZ233526A (en) Pyridazine derivatives and their pharmaceutical compositions
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
JPS5673047A (en) Decaprenylamine derivative

Legal Events

Date Code Title Description
MK1K Patent expired